Stockscreener 앱 받기
1.33
2.22%
-0.02
전일 마감가:
$1.35
열려 있는:
$1.37
하루 거래량:
20,282
Relative Volume:
0.43
시가총액:
$4.82M
수익:
$3,000
순이익/손실:
$-5.16M
주가수익비율:
-0.9411
EPS:
-1.4133
순현금흐름:
$-5.43M
1주 성능:
-1.86%
1개월 성능:
-2.94%
6개월 성능:
-73.23%
1년 성능:
-80.33%
1일 변동 폭
$1.25
$1.385
1주일 범위
$1.25
$1.46
52주 변동 폭
$1.16
$9.37
Pulmatrix Inc Stock (PULM) Company Profile
명칭
Pulmatrix Inc
전화
(888) 355-4440
주소
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
1.32 | 4.93M | 3,000 | -5.16M | -5.43M | -1.4133 |
VRTX
Vertex Pharmaceuticals Inc
|
427.97 | 109.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
744.30 | 79.46B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
785.82 | 48.52B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
305.44 | 40.77B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
299.75 | 33.39B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2018-02-09 | 개시 | H.C. Wainwright | Buy |
Pulmatrix Inc 주식(PULM)의 최신 뉴스
Eos-backed investor takes 9.99% Pulmatrix (PULM) stake ahead merger - Stock Titan
PULM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Pulmatrix, Inc. announced that it has received $1 million in funding - marketscreener.com
Pulmatrix closes $1M preferred stock placement with Eos affiliate - Investing.com
Pulmatrix Closes $1M Series B Preferred Stock Investment at $2.20 per Share as Part of Planned Merger with Eos SENOLYTIX 1 - Minichart
Pulmatrix announces closing of preferred stock transaction as part of planned merger - marketscreener.com
Pulmatrix Announces Closing Of Preferred Stock Transaction As Part Of Planned Merger - TradingView
Pulmatrix closes $1M preferred stock placement with Eos affiliate By Investing.com - Investing.com Canada
Pulmatrix Raises $1M in Preferred Stock Financing - TipRanks
Pulmatrix closes $1M Series B preferred private placement tied to planned merger - TradingView
Pulmatrix (NASDAQ: PULM) closes $1M Series B preferred tied to Eos merger - Stock Titan
Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger - PR Newswire
Pulmatrix (PULM) Stock: Why Working Capital (Trades Higher) 2026-04-20Social Flow Trades - Xã Châu Thành
PULM Stock Alert: Halper Sadeh LLC is Investigating Whether Pulmatrix, Inc. is Obtaining a Fair Price for its Shareholders - The AI Journal
Momentum Shift: Is Pulmatrix Inc in a consolidation phase2026 Recap & Reliable Breakout Stock Forecasts - baoquankhu1.vn
If You Invested $1,000 in Pulmatrix (PULM) - Stock Titan
Stock Recap: Will Pulmatrix Inc benefit from current market trends2026 Historical Comparison & Verified High Yield Trade Plans - baoquankhu1.vn
Gains Report: Will Pulmatrix Inc benefit from seasonality2026 Technical Patterns & Smart Money Movement Tracker - baoquankhu1.vn
Is Pulmatrix (PULM) Stock Good for Beginners | Price at $1.26, Down 4.55%Earnings Breakout - Cổng thông tin điện tử Tỉnh Sơn La
Is Pulmatrix (PULM) Stock Good for Long Term | Price at $1.35, Up 3.05%Reward Analysis - Cổng thông tin điện tử tỉnh Lào Cai
PULM Stock Analysis: Pulmatrix Inc. Biotech At $1.31 Post Minor Daily Decline - Cổng thông tin điện tử tỉnh Tây Ninh
FOMO Trade: Will Pulmatrix Inc benefit from current market trendsQuarterly Trade Review & Consistent Income Trade Recommendations - baoquankhu1.vn
FRA:2PU PB Ratio: 1.34 — 15% Above Median - GuruFocus
Pulmatrix and Eos SENOLYTIX Announce $19 Million Merger to Advance Mitochondrial Therapies - Global Legal Chronicle
Pulmatrix shares dive as privately-held pharma company chooses to merge with Gyre Therapeutics instead - MSN
Ideas Watch: Is Pulmatrix Inc in a consolidation phaseQuarterly Trade Summary & Low Risk Investment Opportunities - baoquankhu1.vn
Pulmatrix and Eos SENOLYTIX Announce $19M Merger to Advance AI-Driven Mitochondrial Therapies for Sarcopenia and Aging-Related Diseases 1 - Minichart
Pulmatrix to Merge With Eos SENOLYTIX, Rebrand on Nasdaq - tipranks.com
Pulmatrix to Merge With Eos SENOLYTIX; Raises $1M Preferred, Eos Secures Up to $18M - TradingView
Pulmatrix (PULM) plans reverse merger with Eos SENOLYTIX, legacy holders keep ~6% - Stock Titan
Haynes Boone Advises on Pulmatrix–Eos Merger and $19MM Financing - ABF Journal
Pulmatrix to acquire Eos SENOLYTIX in $19M anti-aging deal - Investing.com India
Pulmatrix and Eos SENOLYTIX Unite to Pioneer Anti-Aging Therapies Targeting Mitochondrial Health - Beijing Times
Deal Watch: Pulmatrix Finds New Merger Partner In Eos Senolytix - Citeline News & Insights
Eos SENOLYTIX, Inc. agreed to acquire Pulmatrix, Inc. in a reverse merger transaction. - MarketScreener
Aug Fed Impact: Is Pulmatrix Inc forming higher highs and higher lows2026 Market Mood & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Pulmatrix: Merger With Eos SENOLYTIX To Advance Mitochondrial Therapies - Pulse 2.0
Pulmatrix To Merge with Eos SENOLYTIX - citybiz
Pulmatrix (PULM) to Acquire Eos Senolytix in Strategic Merger - GuruFocus
Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan - PR Newswire
Pulmatrix, Inc. announced that it expects to receive $1 million in funding - marketscreener.com
Buyout Rumor: Can Pulmatrix Inc grow without dilution2026 Closing Moves & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Pulmatrix (NASDAQ:PULM) Stock Crosses Above Fifty Day Moving Average – Here’s Why - Defense World
Aug Catalysts: What are the analyst revisions for Vroom IncIs Pulmatrix Inc stock a good investment in YEARTrade Exit Report & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Risk Off: What is the earnings history of Pulmatrix IncWeekly Stock Report & Weekly High Conviction Ideas - baoquankhu1.vn
Why Pulmatrix Inc. stock is a value investor pickJuly 2025 Price Swings & Daily Growth Stock Investment Tips - Naître et grandir
Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead - Stocktwits
Surprises Report: Will Pulmatrix Inc benefit from rising consumer demandShare Buyback & Capital Efficient Trade Techniques - baoquankhu1.vn
Pulmatrix, Inc. (PULM) Competitors - Meyka
Pulmatrix Pursues New Reverse Merger After Cullgen Termination - The Globe and Mail
Pulmatrix merger with Cullgen terminated by Chinese firm - Investing.com
Pulmatrix Inc (PULM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.73%
2.52%
자본화:
|
볼륨(24시간):